ROIV

NASDAQ · Biotechnology

Roivant Sciences Ltd

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$36.34

+1.22 (+3.47%)

As of Aug 8, 9:40 PM ET ·

ROIV News1 articles

Immunovant Shares Surge on Promising Arthritis Drug Data

Immunovant shares soared 35% after its experimental rheumatoid arthritis drug, IMVT-1402, demonstrated high response rates in a difficult-to-treat patient population, prompting a re-rating by Wall Street.